Susquehanna International Group’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-289
| Closed | -$3.28K | – | 14190 |
|
|
2022
Q4 | $3.28K | Buy |
+289
| New | +$3.36K | ﹤0.01% | 12094 |
|
|
2022
Q3 | – | Sell |
-371
| Closed | -$22K | – | 14800 |
|
|
2022
Q2 | $22K | Buy |
371
+337
| +991% | +$48.9K | ﹤0.01% | 12351 |
|
|
2022
Q1 | $14K | Sell |
34
-17
| -33% | -$10.9K | ﹤0.01% | 12707 |
|
|
2021
Q4 | $50K | Buy |
51
+5
| +11% | +$7.05K | ﹤0.01% | 12548 |
|
|
2021
Q3 | $89K | Sell |
46
-56
| -55% | -$127K | ﹤0.01% | 12131 |
|
|
2021
Q2 | $272K | Buy |
102
+29
| +40% | +$95.6K | ﹤0.01% | 10992 |
|
|
2021
Q1 | $303K | Sell |
73
-33
| -31% | -$178K | ﹤0.01% | 10589 |
|
|
2020
Q4 | $609K | Buy |
106
+18
| +20% | +$106K | ﹤0.01% | 7857 |
|
|
2020
Q3 | $537K | Sell |
88
-42
| -32% | -$241K | ﹤0.01% | 7516 |
|
|
2020
Q2 | $725K | Sell |
130
-201
| -61% | -$1.04M | ﹤0.01% | 6591 |
|
|
2020
Q1 | $1.23M | Buy |
331
+250
| +309% | +$1.43M | ﹤0.01% | 4909 |
|
|
2019
Q4 | $405K | Buy |
81
+54
| +200% | +$189K | ﹤0.01% | 7403 |
|
|
2019
Q3 | $63K | Buy |
+27
| New | +$66.5K | ﹤0.01% | 9719 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 11294 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 10914 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 11090 |
|
|
2018
Q3 | – | Sell |
-8
| Closed | -$8K | – | 11292 |
|
|
2018
Q2 | $8K | Sell |
8
-38
| -83% | -$133K | ﹤0.01% | 9473 |
|
|
2018
Q1 | $235K | Buy |
+46
| New | +$304K | ﹤0.01% | 8058 |
|
|
2017
Q4 | – | Sell |
-8
| Closed | -$74.5K | – | 10685 |
|
|
2017
Q3 | $68K | Sell |
8
-19
| -70% | -$146K | ﹤0.01% | 8467 |
|
|
2017
Q2 | $205K | Buy |
+27
| New | +$187K | ﹤0.01% | 8246 |
|
|
2017
Q1 | – | Sell |
-11
| Closed | -$121K | – | 10607 |
|
|
2016
Q4 | $121K | Buy |
+11
| New | +$154K | ﹤0.01% | 8987 |
|
Other funds holding AGRX
VF
IA
ASN
BBA